We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Myelin-Producing Cells Restore Nerve Function in Mice

By Biotechdaily staff writers
Posted on 21 Jan 2004
By introducing myelin-producing cells in widespread areas of the brain in mice, scientists have been able to restore proper nerve function in nearly the entire brain more efficiently than was previously possible, offering the possibility of treatment for demyelinating diseases. More...
The findings were reported in the January 2004 issue of Nature Medicine.

Myelin is a fatty substance that covers nearly all the nerve cells in the body and helps signals in the nervous system go from one point to another. When myelin breaks down, electrical signals degrade. This can result in a number of disorders as well as such diseases as Canavan disease in children and multiple sclerosis (MS). Currently, demyelinating diseases are permanent, with no available therapy.

The investigators remyelinated the mice by injecting highly purified human progenitor cells, which ultimately evolved into the cells that make myelin, called oligodendrocytes. They studied 44 mice born without any myelin wrapped around their brain cells. Within 24 hours, they injected the mice and found that the cells quickly migrated throughout the brain, developing into oligodendrocytes and producing myelin. The team found that adult human cells were much more adept at settling into the brain, becoming oligodendrocytes and producing myelin, than fetal cells.

"The results are much better than we expected,” said team leader Steven Goldman, M.D., Ph.D., professor of neurology at the University of Rochester Medical Center (NY, USA; www.rochester.edu). "The percentage of cells in this experiment that began producing myelin is extraordinary, probably thousands of times as many as in previous experiments.”




Related Links:
University of Rochester

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.